| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000045027 |
| Receipt No. | R000050821 |
| Scientific Title | Prospective observational study to establish the indications for staging laparoscopy in pancreatic cancer |
| Date of disclosure of the study information | 2021/08/01 |
| Last modified on | 2021/07/31 (Ver. 1) |
| Basic information | ||
| Public title | Prospective observational study to establish the indications for staging laparoscopy in pancreatic cancer | |
| Acronym | Prospective observational study to establish the indications for staging laparoscopy in pancreatic cancer | |
| Scientific Title | Prospective observational study to establish the indications for staging laparoscopy in pancreatic cancer | |
| Scientific Title:Acronym | Prospective observational study to establish the indications for staging laparoscopy in pancreatic cancer | |
| Region |
|
|
| Condition | ||
| Condition | Pancreatic cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To establish the indications for staging laparoscopy in pancreatic cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Analysis of risk factors predicting radiologically undetectable micrometastases in pancreatic cancer |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Patients who are histologically or cytologically diagnosed as pancreatic cancer
(2) No distant metastasis in radiological imaging tests at the initial diagnosis (3) Pancreatic cancer patients determined to have indications of treatment intended for resection |
|||
| Key exclusion criteria | (1) Patients who are not histologically or cytologically diagnosed as pancreatic cancer
(2) Distant metastasis in radiological imaging tests (3) Patients with concurrent active multiple cancers at the enrollment (4) Patients with poor general condition who are determined to have no indication for staging laparoscopy or treatment intended for resection |
|||
| Target sample size | 160 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tohoku University | ||||||
| Division name | Department of Surgery | ||||||
| Zip code | 980-8574 | ||||||
| Address | 1-1 Seiryomachi, Aobaku, Sendai, Japan | ||||||
| TEL | 022-717-7205 | ||||||
| masamichi@surg.med.tohoku.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tohoku University | ||||||
| Division name | Department of Surgery | ||||||
| Zip code | 980-8574 | ||||||
| Address | 1-1 Seiryomachi, Aobaku, Sendai, Japan | ||||||
| TEL | 022-717-7205 | ||||||
| Homepage URL | |||||||
| masamichi@surg.med.tohoku.ac.jp | |||||||
| Sponsor | |
| Institute | Tohoku University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | KUROKAWA CANCER RESEARCH FOUNDATION |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tohoku University |
| Address | 1-2 Seiryomachi, Aobaku, Sendai, Japan |
| Tel | 022-717-7056 |
| med-kenkyo@grp.tohoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | none |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050821 |